MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 17, Issue 10, Pages 1207-1217
Publisher
Wiley
Online
2013-10-12
DOI
10.1111/jcmm.12131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples
- (2013) Xiao Li et al. BMC CANCER
- Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel
- (2013) Hao Wu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Downregulation of miR-17~92 Expression Increase Paclitaxel Sensitivity in Human Ovarian Carcinoma SKOV3-TR30 Cells via BIM Instead of PTEN
- (2013) Ting Shuang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-Mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma
- (2013) Shi-Yun Cui et al. MOLECULAR CANCER RESEARCH
- Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET
- (2013) T Mitamura et al. Oncogenesis
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- MiRNA-21
- (2012) Wen Gao et al. CANCER BIOLOGY & THERAPY
- Reversal of Paclitaxel Resistance in Epithelial Ovarian Carcinoma Cells by a MUC1 Aptamer-let-7i Chimera
- (2012) Nenghui Liu et al. CANCER INVESTIGATION
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
- (2012) Libero Santarpia et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- miR-125b Functions as a Key Mediator for Snail-induced Stem Cell Propagation and Chemoresistance
- (2012) Zixing Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
- (2012) S Catuogno et al. ONCOGENE
- Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a miRNA in Breast Cancer Cells
- (2012) Kezhen Lv et al. PLoS One
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- miRNA-34a is associated with docetaxel resistance in human breast cancer cells
- (2011) L. Kastl et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3
- (2011) Bing Feng et al. CANCER
- MicroRNA-21: A novel therapeutic target in human cancer
- (2011) Xuan Pan et al. CANCER BIOLOGY & THERAPY
- miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression
- (2011) Jian Li et al. CANCER LETTERS
- MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1
- (2011) Bing Feng et al. CANCER LETTERS
- Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells
- (2011) Sharon Lobert et al. Cytoskeleton
- PLK1 as an oncology target: current status and future potential
- (2011) Campbell McInnes et al. DRUG DISCOVERY TODAY
- Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein
- (2011) Bao Hua Li et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA let-7a: A potential marker for selection of paclitaxel in ovarian cancer management
- (2011) Lingeng Lu et al. GYNECOLOGIC ONCOLOGY
- Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
- (2011) Benjamin Boyerinas et al. INTERNATIONAL JOURNAL OF CANCER
- Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer
- (2011) Fiona Furlong et al. JOURNAL OF PATHOLOGY
- MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2
- (2011) Ji-guang Zhang et al. Journal of Thoracic Oncology
- Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells
- (2011) Jian Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
- (2011) Bin Xu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Unknown
- (2011) Murielle Mimeault et al. MOLECULAR MEDICINE
- miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo
- (2011) A Holleman et al. ONCOGENE
- MicroRNAs as therapeutic targets in cancer
- (2011) S. Patrick Nana-Sinkam et al. Translational Research
- Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
- (2010) Guo-hai Shi et al. ACTA PHARMACOLOGICA SINICA
- Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions
- (2010) Li Xie et al. BMC CANCER
- MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
- (2010) Yu Ren et al. BMC CANCER
- The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment
- (2010) Kelly K. Haagenson et al. CANCER AND METASTASIS REVIEWS
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?
- (2010) Simone Brabletz et al. EMBO REPORTS
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance
- (2010) Yuemeng Dai et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression
- (2010) Yasunori Fujita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
- (2010) Dan-Dan Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- miR-21: an oncomir on strike in prostate cancer
- (2010) Marco Folini et al. Molecular Cancer
- Human Mutations That Confer Paclitaxel Resistance
- (2010) S. Yin et al. MOLECULAR CANCER THERAPEUTICS
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol
- (2010) S Radulescu et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Inhibition of c-FLIP expression by miR-512-3p contributes to Taxol-induced apoptosis in hepatocellular carcinoma cells
- (2010) Chen ONCOLOGY REPORTS
- Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy
- (2010) Hai-Liang Zhang et al. PROSTATE
- MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms
- (2010) Keitaro Kojima et al. PROSTATE
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth
- (2009) M. Shiota et al. CANCER RESEARCH
- The miR-34 family in cancer and apoptosis
- (2009) H Hermeking CELL DEATH AND DIFFERENTIATION
- MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy
- (2009) Todd Boren et al. GYNECOLOGIC ONCOLOGY
- Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1)
- (2009) Wang Rui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- Cell Death
- (2009) Richard S. Hotchkiss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
- (2009) R. E. Lanford et al. SCIENCE
- Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3
- (2008) Wing Pui Tsang et al. APOPTOSIS
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
- (2008) Qing Ji et al. BMC CANCER
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
- miR-21: a small multi-faceted RNA
- (2008) Anna M. Krichevsky et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer
- (2008) Kelly H. Salter et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started